[1]Gao JP, Xu W, Liu WT,et al.Tumor heterogeneity of gastric cancer: From the perspective of tumorinitiating cell\[J\].World J Gastroenterol,2018,24(24): 2567-2581.
[2]Kang WM,Meng QB,Yu JC,et al.Factors associated with early recurrence after curative surgery for gastric cancer\[J\].World J Gastroenterol,2015,21(19):5934-5940.
[3]Degiuli M,Calvo F.Survival of early gastric cancer in specialized European center.Which lymphadenectomy is necessary? \[J\].World J Surg,2006,30(12):2193-2203.
[4]Liu L,Wang ZW, Ji J,et al.A cohort study and metaanalysis between histopathological classification and prognosis of gastric carcinoma\[J\]. Anticancer Agents Med Chem, 2013,13(2):27-34.
[5]Lai JF,Xu WN,Noh SH,et al.Effect of World Health Organization (WHO) histological classification on predicting lymph node metastasis and recurrence in early gastric cancer\[J\]. Med Sci Monit, 2016, 22: 3147-3153.
[6]凌斌勋,陈环球,徐新宇,等.33例胃印戒细胞癌的临床分析[J].临床肿瘤学杂志,2011,16(11):1013-1015.
[7]Kumar V, Gu Y, Basu S, et al. Radiomics:the process and the challenges\[J\]. Magn Reson Imaging, 2012,30(8):1234-1248.
[8]Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures,they are data\[J\]. Radiology,2016, 278(2):563-577.
[9]Peng H, Dong D, Fang MJ, et al. Prognostic value of deep learning PET/CTbased radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma\[J\].Clin Cancer Res, 2019,25(14):4271-4279.
[10]Song JD, Shi JY, Dong D, et al. A new approach to predict progressionfree survival in stage Ⅳ EGFRmutant NSCLC patients with EGFRTKI therapy\[J\]. Clin Cancer Res, 2018,24(15): 3583-3592.
[11]Ma Z, Fang M, Huang Y, et al. CTbased radiomics signature for differentiating Borrmann typeⅣ gastric cancer from primary gastric lymphoma\[J\]. Eur J Radiol, 2017, 91(23): 142-147.
[12]BaSsalamah A, Muin D, Schernthaner R, et al. Texturebased classification of different gastric tumors at contrastenhanced CT\[J\].Radiology, 2013, 82(10): 537-543.
[13]Dong D, Tang L,Li ZY, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer\[J\].Ann Oncol,2019,30(3):431-438.
[14]焦旭光,梁寒,邓靖宇,等.混合组织学类型胃癌临床病理特点及预后分析\[J\].中华胃肠外科杂志,2013,16(3):260-263.
[15]于颖彦,朱正纲. 2010 版WHO 胃肿瘤临床病理学分类及分期解读\[J\]. 外科理论与实践,2011,16 (5):508-512.
[16]张云,姚萍,崔旻,等.临床病理特征与早期胃癌分化程度的关系\[J\].中华实用诊断与治疗杂志,2019,33(5):443-445.
[17]Ho SWT, Tan P.Dissection of gastric cancer heterogeneity for precision oncology\[J\].Cancer Sci,2019,110(11):1-10.
[18]邹茹欣,周洋,巴志昌,等.进展期胃癌64排螺旋CT三期增强影像强化特点与组织学分型相关性的研究\[J\].实用肿瘤学杂志,2013,27(6):549-553.
[19]高剑波,杨学华,李萌太,等.进展期与早期胃癌螺旋CT三期增强的诊断价值[J].中华放射学杂志,2001,35(4):253-257.
[20]Liu S, Liu S, Ji C, et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers\[J\]. Eur Radiol, 2017, 27(12): 4951-4959.
[21]Lin X, Yang F, Zhou L,et al. A support vector machinerecursive feature elimination feature selection method based on artificial contrast variables and mutual information\[ J\]. J Chromatogr B, 2012, 910: 149-155.
[22]郭震,王春祥,王培林,等.胃癌患者血浆胆固醇、LDL与胃癌组织病理分型的相关性研究\[J\].山东大学学报(医学版),2007,45(2): 160-162. |